325 related articles for article (PubMed ID: 11288962)
21. Is aliskiren superior to inhibitors of angiotensin-converting enzyme and angiotensin receptor blockers in renin-angiotensin system blockade?
Gerc V; Buksa M; Loza V; Kulic M
Med Arh; 2009; 63(6):343-9. PubMed ID: 20380117
[TBL] [Abstract][Full Text] [Related]
22. Interrupting the renin-angiotensin system: the role of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of hypertension.
Weber MA
Am J Hypertens; 1999 Dec; 12(12 Pt 3):189S-194S. PubMed ID: 10619571
[TBL] [Abstract][Full Text] [Related]
23. The benefit of angiotensin AT1 receptor blockers for early treatment of hypertensive patients.
Trimarco B; Santoro C; Pepe M; Galderisi M
Intern Emerg Med; 2017 Dec; 12(8):1093-1099. PubMed ID: 28770426
[TBL] [Abstract][Full Text] [Related]
24. Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension.
Li EC; Heran BS; Wright JM
Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD009096. PubMed ID: 25148386
[TBL] [Abstract][Full Text] [Related]
25. ACE-Inhibitors in Hypertension: A Historical Perspective and Current Insights.
Cutrell S; Alhomoud IS; Mehta A; Talasaz AH; Van Tassell B; Dixon DL
Curr Hypertens Rep; 2023 Sep; 25(9):243-250. PubMed ID: 37284934
[TBL] [Abstract][Full Text] [Related]
26. Role of valsartan and other angiotensin receptor blocking agents in the management of cardiovascular disease.
Martin J; Krum H
Pharmacol Res; 2002 Sep; 46(3):203-12. PubMed ID: 12220962
[TBL] [Abstract][Full Text] [Related]
27. Advantages of renin-angiotensin system blockade in the treatment of cardiovascular diseases.
Gerc V; Buksa M
Med Arh; 2010; 64(5):295-9. PubMed ID: 21287956
[TBL] [Abstract][Full Text] [Related]
28. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
[TBL] [Abstract][Full Text] [Related]
29. Optimal antagonism of the Renin-Angiotensin-aldosterone system: do we need dual or triple therapy?
Werner C; Pöss J; Böhm M
Drugs; 2010 Jul; 70(10):1215-30. PubMed ID: 20568830
[TBL] [Abstract][Full Text] [Related]
30. [The future of renin inhibition].
Uresin AY; Baran E
Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():32-8. PubMed ID: 20019475
[TBL] [Abstract][Full Text] [Related]
31. Impact of angiotensin II on the kidney: does an angiotensin II receptor blocker make sense?
Hollenberg NK
Am J Kidney Dis; 2000 Sep; 36(3 Suppl 1):S18-23. PubMed ID: 10986155
[TBL] [Abstract][Full Text] [Related]
32. Renin-angiotensin system blockade at the level of the angiotensin converting enzyme or the angiotensin type-1 receptor: similarities and differences.
Stergiou GS; Skeva II
Curr Top Med Chem; 2004; 4(4):473-81. PubMed ID: 14965313
[TBL] [Abstract][Full Text] [Related]
33. The Divergent Cardiovascular Effects of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Myocardial Infarction and Death.
Strauss MH; Hall AS
Prog Cardiovasc Dis; 2016; 58(5):473-82. PubMed ID: 26586276
[TBL] [Abstract][Full Text] [Related]
34. Renin-angiotensin system blocking drugs.
Robles NR; Cerezo I; Hernandez-Gallego R
J Cardiovasc Pharmacol Ther; 2014 Jan; 19(1):14-33. PubMed ID: 24038019
[TBL] [Abstract][Full Text] [Related]
35. The renin-angiotensin system: the role of inhibitors, blockers, and genetic polymorphisms in the treatment and prevention of heart failure.
Hebert PR; Foody JM; Hennekens CH
Curr Vasc Pharmacol; 2003 Mar; 1(1):33-9. PubMed ID: 15320851
[TBL] [Abstract][Full Text] [Related]
36. Should ACE inhibitors and ARBs be used in combination in children?
Stotter BR; Ferguson MA
Pediatr Nephrol; 2019 Sep; 34(9):1521-1532. PubMed ID: 30112656
[TBL] [Abstract][Full Text] [Related]
37. Blockade of renin angiotensin system in heart failure post-myocardial infarction: what is the best therapy?
E Gullo C; de Almeida Zia VA; Vilela-Martin JF
Recent Pat Cardiovasc Drug Discov; 2014; 9(1):28-37. PubMed ID: 24993597
[TBL] [Abstract][Full Text] [Related]
38. [Oral inhibitors of renin and their potential use as therapeutic agents in treating hypertension].
Abassi Z; Armaly Z; Nakhoul F; Hoffman A
Harefuah; 2008 Jun; 147(6):536-42, 573. PubMed ID: 18693632
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin converting enzyme inhibitors and angiotensin receptor blockers in the treatment of hypertension: should they be used together?
Verdecchia P; Angeli F; Mazzotta G; Ambrosio G; Reboldi G
Curr Vasc Pharmacol; 2010 Nov; 8(6):742-6. PubMed ID: 20626343
[TBL] [Abstract][Full Text] [Related]
40. Mega clinical trials which have shaped the RAS intervention clinical practice.
Düsing R
Ther Adv Cardiovasc Dis; 2016 Jun; 10(3):133-50. PubMed ID: 27271312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
